XNCR
Xencor Inc
Xencor Inc (XNCR) has 17 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Jul 8, 2026.
Insiders have net sold $792K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Bassil I. Dahiyat
- Employees:250
- HQ:Pasadena, CA, US
- IPO:2013-12-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$792K
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Market Cap
$1.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Feigal EllenFirst filing | Director | Sale | 6,843 | $89K | Jun 22 | SEC ↗ |
Montgomery Alan BruceFirst filing | Director | Sale | 5,064 | $62K | Jun 17 | SEC ↗ |
| Director | Sale | 5,474 | $67K | Jun 17 | SEC ↗ | |
| Director | Sale | 7,527 | $93K | Jun 17 | SEC ↗ | |
RANIERI RICHARD JFirst filing | Director | Sale | 5,474 | $67K | Jun 17 | SEC ↗ |
Cornelissen Bart JanFirst filing | SR. VICE PRESIDENT & CFO | Sale | 3,499 | $43K | Apr 13 | SEC ↗ |
Dahiyat Bassil IFirst filing | PRESIDENT & CEO | Sale | 14,870 | $167K | Mar 9 | SEC ↗ |
Dahiyat Bassil IFirst filing | PRESIDENT & CEO | Sale | 6,606 | $73K | Mar 9 | SEC ↗ |
Desjarlais John RFirst filing | SR. VICE PRESIDENT & CSO | Sale | 4,118 | $46K | Mar 9 | SEC ↗ |
Desjarlais John RFirst filing | SR. VICE PRESIDENT & CSO | Sale | 2,502 | $28K | Mar 9 | SEC ↗ |
Eckert CeliaFirst filing | SVP, GENERAL COUNSEL | Sale | 3,244 | $36K | Mar 9 | SEC ↗ |
Eckert CeliaFirst filing | SVP, GENERAL COUNSEL | Sale | 1,767 | $19K | Mar 9 | SEC ↗ |
Related companies
Xencor Inc is in the Healthcare sector.